FATE
Fate Therapeutics, Inc.
stockNASDAQ
At CloseOct 30, 2026 2:17:38 PM EDT
2.05USD-5.760%(-0.12)1,064,419
Pre-marketOct 30, 2026 10:23:50 AM EDT
2.04USD-6.221%(-0.14)
FATE Financials
In Q2 FY 2026 (ended ), Fate Therapeutics, Inc. (FATE) reported revenue of $2.08M, net income of −$30.16M, operating cash flow of −$23.4M, and assets of $260.1M.
Loading financial flows…